53 min listen
Myeloma at ASH 2020: talquetemab, CARTITUDE-1 & highlights
FromVJHemOnc Podcast
ratings:
Length:
14 minutes
Released:
Jan 20, 2021
Format:
Podcast episode
Description
The field of multiple myeloma is rapidly evolving and can be credited to an increased understanding of the biology of...
The post Myeloma at ASH 2020: talquetemab, CARTITUDE-1 & highlights appeared first on VJHemOnc.
The post Myeloma at ASH 2020: talquetemab, CARTITUDE-1 & highlights appeared first on VJHemOnc.
Released:
Jan 20, 2021
Format:
Podcast episode
Titles in the series (100)
The AML Sessions: emerging immunotherapies, venetoclax-based regimens and targeted therapies in AML: The acute myeloid leukemia (AML) field has witnessed rapid evolution of late, with exciting developments in strategies for the treatment... by VJHemOnc Podcast